NewsAI-assisted

ACG Joins Forces With EY-Parthenon For Strategic Partnership

ACG partners with EY-Parthenon to achieve net zero emissions, align with SBTi, and comply with EU CBAM, focusing on reducing carbon footprint.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Jun 13, 2024Updated Jun 26, 2025 · 2 min read
ACG Joins Forces With EY-Parthenon For Strategic Partnership
https://www.google.com/search?q=stratergic+Partnership&tbm=isch&ved=2ahUKEwjCicTdqdiGAxXz-DgGHfNRCjcQ2-cCegQIABAA&oq=stratergic+Partnership&gs_lp=EgNpbWciFnN0cmF0ZXJnaWMgUGFydG5lcnNoaXAyCRAAGIAEGBgYCkiGJVDEDVjkI3AAeACQAQCYAdYBoAHTC6oBBjAuMTEuMbgBA8gBAPgBAYoCC2d3cy13aXotaW1nwgIIEAAYgAQYsQPCAgsQABiABBixAxiDAcICBRAAGIAEwgIGEAAYBxgeiAYB&sclient=img&ei=5sNqZsL-EvPx4-EP86OpuAM&bih=919&biw=1920&rlz=1C1VDKB_enIN1103IN1103&hl=en#imgrc=qQnbCd1Up1YJAM
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

ACG has teamed up with EY-Parthenon to strengthen its sustainability efforts by developing a detailed plan for achieving net zero emissions. Moreover, this partnership will also focus on aligning with the SBTi i.e., Science Based Targets initiative, a widely respected framework that helps companies set emissions reduction goals based on current climate science.

The collaboration between the two companies aims to greatly cut down on carbon emissions and advance sustainable practices throughout ACG’s operations. To kickstart this effort, they have started by conducting a thorough inventory of greenhouse gas emissions (GHG) and assessing the carbon footprint of their flagship products.

Due to ACG’s substantial export of aluminium-based films and foils to the European Union, EY Parthenon has undertaken a detailed evaluation of the implications of the Carbon Border Adjustment Mechanism (CBAM) for ACG. This assessment aims to ensure that ACG achieves full compliance with CBAM requirements. It has also offered valuable insights into ACG’s emissions profile, pinpointing key areas where focused sustainability initiatives are needed.

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →